FDA Inspection 1099955 — Phraxis, Inc.

Phraxis, Inc. — FEI 3014146191

The FDA completed an inspection of Phraxis, Inc. on August 20, 2019 in Minneapolis, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 20, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Minneapolis, MN (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
292821 CFR 812.40Sponsors' general responsibilities